DrugPipeline.net has announced the addition of “US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore” research report to their website www.DrugPipeline.net
Bangalore, India -- (SBWIRE) -- 01/12/2018 -- VSDs are defects in the ventricular septum, the wall dividing the left and right ventricles of the heart. VSDs are similar to ASDs but tend to cause fewer complications because VSDs are small and most people with the defect barely feel the symptoms. However, approximately 10% of individuals with VSD will develop Eisenmenger's Syndrome, which is a condition that can curtail life expectancy by several years.
This condition can also be found in ASD patients. VSDs are found in approximately 3 to 3.5 of every 1,000 births but the vast majority of VSDs are likely to close spontaneously during childhood. Only in a small percentage of cases, they will have to be treated surgically. ASDs and VSDs can be treated percutaneously by inserting a device through the defect, which expands and forms a seal around the defect. Many of these devices allow heart tissue to grow over the device with time.
Atrial septal defect (ASD) and ventricular septal defect (VSD) are both conditions that involve incorrect blood flow within the heart. ASD is an opening in the muscular tissue that separates the sides of the heart's two upper chambers. Due to blood reflux, the heart is made to work more strenuously and below its optimal level.
The condition is more common in females than males and tends to get worse with time. If left untreated, ASD can cause hypertension, heart arrhythmia and even a stroke. As with patent foramen ovale (PFO), ASD can be treated with open-heart surgery, but the operation is highly invasive. ASDs are found in approximately 1 in 1,500 live births and can lead to death if not treated in some cases.
Spanning over 384 pages "US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore" report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, Product Portfolio, Atrial And Ventricular Septal Defect Device Market, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.
For more information Visit at: https://www.drugpipeline.net/idata-research/us-market-report-atrial-and-ventricular-septal-defect-devices-2018-medcore
Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare
US Market Report for Remote Hemodynamic Monitoring Systems 2018 - MedCore - Visit at - https://www.drugpipeline.net/idata-research/us-market-report-remote-hemodynamic-monitoring-systems-2018-medcore
US Market Report for Patent Foramen Ovale Devices 2018 - MedCore - Visit at - https://www.drugpipeline.net/idata-research/us-market-report-patent-foramen-ovale-devices-2018-medcore
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.